Bult, Johanna A. A.
Huisman, Francien
Zhong, Yujie
Veltmaat, Nick
Kluiver, Joost
Tonino, Sanne H.
Vermaat, Joost S. P. http://orcid.org/0000-0002-1628-6256
Chamuleau, Martine E. D. http://orcid.org/0000-0002-0123-9182
Diepstra, Arjan http://orcid.org/0000-0001-9239-1050
van den Berg, Anke http://orcid.org/0000-0002-8894-2638
Plattel, Wouter J.
Brink, Mirian http://orcid.org/0000-0002-6014-4810
Nijland, Marcel http://orcid.org/0000-0002-2740-2873
Funding for this research was provided by:
Sanne H. Tonino has received consultation fees from van Takeda, Incyte Biosciences, Roche Pharma
Celgene
Bristol-Myers Squibb
Gilead Sciences
Martine E.D. Chamuleau received financial support for clinical trials from Celgene, Bristol-Myers Squibb, and Gilead.
Arjan Diepstra received research funding from Takeda
Article History
Received: 2 June 2023
Revised: 3 August 2023
Accepted: 15 August 2023
First Online: 1 September 2023
Competing interests
: ST received consultation fees from van Takeda, Incyte Biosciences, and Roche Pharma. MC received financial support for clinical trials from Celgene, Bristol-Myers Squibb, and Gilead. AD received research funding from Takeda. The remaining authors declare no competing financial interests.